However, the proportion of participants achieving HbA1c levels <6.5% at Week 24 did not reach statistical significance (Figure S3B ).
← all excerpts
EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study).
1
—
—